Literature DB >> 15607380

Drug coverage in Canada: who is at risk?

Vishnu Kapur1, Kisalaya Basu.   

Abstract

Drugs are playing an increasingly important role in health care. However, unlike physician care and hospital care, Canadians do not have universal coverage for drugs. Generally, many employers provide drug coverage as part of employment benefits. In addition, provincial governments provide coverage to some parts of the population, generally, seniors and families on social assistance. Two important recent reports on the state of health care in Canada--the Kirby and Romanow reports--focus on the need for relief to families for rising cost of drugs. Policy makers need good information not only on the likely costs of such a project but also the impact of increasing drug costs on individuals and families with significant drug expenses. One of the keys to assessing scenarios for such relief is knowledge about the extent and depth of existing drug insurance coverage. However, the needed information is scattered over a number of data sources. We have put together a comprehensive and cohesive micro database synthesizing data from these diverse sources. The resultant micro database contains individual/family drug coverage information arrayed by socio-economic characteristics. This paper uses the data set to conduct an extensive analysis of the extent of drug coverage under public and private drug plans in Canada. The paper then goes on to analyze the level of such coverage in terms of out-of-pocket drug expenses faced by Canadian families in an effort to identify gaps in coverage.

Mesh:

Year:  2005        PMID: 15607380     DOI: 10.1016/j.healthpol.2004.08.006

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  16 in total

1.  Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.

Authors:  Jamie R Daw; Steven G Morgan
Journal:  Health Policy       Date:  2011-10-05       Impact factor: 2.980

2.  Costs and benefits of free medications after myocardial infarction.

Authors:  Irfan A Dhalla; Monique A Smith; Niteesh K Choudhry; Avram E Denburg
Journal:  Healthc Policy       Date:  2009-11

3.  Addressing cost-related barriers to prescription drug use in Canada.

Authors:  Karen L Tang; William A Ghali; Braden J Manns
Journal:  CMAJ       Date:  2013-09-16       Impact factor: 8.262

4.  The financial burden of out of pocket prescription drug expenses in Canada.

Authors:  Sam Caldbick; Xiaojing Wu; Tom Lynch; Naser Al-Khatib; Mustafa Andkhoie; Marwa Farag
Journal:  Int J Health Econ Manag       Date:  2015-03-24

5.  Coping strategies used by patients infected with hepatitis C virus who are facing medication costs.

Authors:  Chiranjeev Sanyal; Ethel Langille Ingram; Ingrid S Sketris; Kevork M Peltekian; Susan Kirkland
Journal:  Can J Hosp Pharm       Date:  2011-03

6.  Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort.

Authors:  Deborah M Levy; Christine A Peschken; Lori B Tucker; Gaëlle Chédeville; Adam M Huber; Janet E Pope; Earl D Silverman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-01       Impact factor: 4.794

7.  The effect of cost on adherence to prescription medications in Canada.

Authors:  Michael R Law; Lucy Cheng; Irfan A Dhalla; Deborah Heard; Steven G Morgan
Journal:  CMAJ       Date:  2012-01-16       Impact factor: 8.262

8.  Prescription medication nonadherence associated with food insecurity: a population-based cross-sectional study.

Authors:  Fei Men; Craig Gundersen; Marcelo L Urquia; Valerie Tarasuk
Journal:  CMAJ Open       Date:  2019-09-23

9.  Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.

Authors:  Virginie Demers; Magda Melo; Cynthia Jackevicius; Jafna Cox; Dimitri Kalavrouziotis; Stéphane Rinfret; Karin H Humphries; Helen Johansen; Jack V Tu; Louise Pilote
Journal:  CMAJ       Date:  2008-02-12       Impact factor: 8.262

10.  Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.

Authors:  Logan McLeod; Basil G Bereza; Minsup Shim; Paul Grootendorst
Journal:  Open Med       Date:  2011-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.